My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 159

    1.

    Epithelial carcinoma of the ovary: current strategies.

    Katz ME, Schwartz PE, Kapp DS, Luikart S.

    Ann Intern Med. 1981 Jul;95(1):98-111.PMID: 6787963 [PubMed - indexed for MEDLINE]Related articles

    2.

    Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.

    Piver MS.

    Oncologist. 1996;1(5):326-330.PMID: 10388011 [PubMed - as supplied by publisher]Related articlesFree article

    3.

    Gynecological malignancies.

    Schaebler DL, Schilder RJ, Young RC.

    Cancer Chemother Biol Response Modif. 1996;16:564-91. Review.PMID: 8639401 [PubMed - indexed for MEDLINE]Related articles

    4.

    Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.

    Wadler S, Yeap B, Vogl S, Carbone P.

    Cancer. 1996 Feb 15;77(4):733-42.PMID: 8616766 [PubMed - indexed for MEDLINE]Related articles

    5.

    Medical therapy of advanced malignant epithelial tumours of the ovary.

    Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.

    Forum (Genova). 2000 Oct-Dec;10(4):323-32. Review.PMID: 11535983 [PubMed - indexed for MEDLINE]Related articles

    6.

    High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.

    Firat S, Murray K, Erickson B.

    Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):201-7.PMID: 12909234 [PubMed - indexed for MEDLINE]Related articles

    7.

    Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.

    Dusenbery KE, Bellairs EE, Potish RA, Twiggs LB, Boente MP.

    Gynecol Oncol. 2005 Feb;96(2):307-13.PMID: 15661213 [PubMed - indexed for MEDLINE]Related articles

    8.

    Perspectives on research in gynecologic oncology.

    DeVita VT Jr, Wasserman TH, Young RC, Carter SK.

    Cancer. 1976 Jul;38(1 SUPPL):509-25. Review.PMID: 776390 [PubMed - indexed for MEDLINE]Related articles

    9.

    Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.

    Sood BM, Jones J, Gupta S, Khabele D, Guha C, Runowicz C, Goldberg G, Fields A, Anderson P, Vikram B.

    Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):208-16.PMID: 12909235 [PubMed - indexed for MEDLINE]Related articles

    10.

    Chronic administration of single weekly paclitaxel in heavily pretreated ovarian cancer patients.

    Yamamoto K, Oogi S, Inoue H, Kudoh K, Kita T, Kikuchi Y.

    Curr Med Chem. 2004 Feb;11(4):425-8.PMID: 14965223 [PubMed - indexed for MEDLINE]Related articles

    11.

    Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.

    Veras E, Deavers MT, Silva EG, Malpica A.

    Am J Surg Pathol. 2007 May;31(5):774-82.PMID: 17460463 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Chemotherapy of advanced epithelial ovarian carcinoma]

    Meerpohl HG.

    Onkologie. 1984 May;7 Suppl 2:22-34. Review. German. PMID: 6431349 [PubMed - indexed for MEDLINE]Related articles

    13.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

    14.

    Advances in the management of epithelial ovarian cancer.

    Berkenblit A, Cannistra SA.

    J Reprod Med. 2005 Jun;50(6):426-38. Review.PMID: 16050567 [PubMed - indexed for MEDLINE]Related articles

    15.

    Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.

    Colozza M, Mosconi AM, Gori S, Belsanti V, Basurto C, De Angelis V, Giansanti M, Tonato M.

    Am J Clin Oncol. 1997 Oct;20(5):522-6.PMID: 9345342 [PubMed - indexed for MEDLINE]Related articles

    16.

    Thymoma. A retrospective study of 87 cases.

    Park HS, Shin DM, Lee JS, Komaki R, Pollack A, Putnam JB, Cox JD, Hong WK.

    Cancer. 1994 May 15;73(10):2491-8.PMID: 8174044 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.

    Petit T, Velten M, d'Hombres A, Marchal C, Montbarbon X, Mornex F, Quetin P, Gérard JP, Romestaing P, Carrie C.

    Gynecol Oncol. 2007 Jan;104(1):104-8. Epub 2006 Sep 20.PMID: 16987544 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Expectations and defeat in the treatment of epithelial cancer of the ovary]

    Weil M, Borel C, Auclerc G, Forget G, Durandin-Truffinet M, Thill L, Khayat D, Jacquillat C.

    Ann Med Interne (Paris). 1990;141(1):15-9. French. PMID: 2321883 [PubMed - indexed for MEDLINE]Related articles

    19.

    Clinical analysis and evaluation of the results of adjuvant treatment (radiotherapy and chemotherapy) in ovarian carcinoma.

    Pietrzak K, Sablińska B, Zieliński J.

    Eur J Gynaecol Oncol. 1993;14 Suppl:133-9.PMID: 7515347 [PubMed - indexed for MEDLINE]Related articles

    20.

    The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.

    Silva EG, Gershenson DM, Malpica A, Deavers M.

    Am J Surg Pathol. 2006 Nov;30(11):1367-71.PMID: 17063075 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity